VOLTAGE: Multicenter phase 1b/II study of nivolumab monotherapy and subsequent radical surgery after preoperative chemoradiotherapy with capecitabine in patients with locally advanced rectal cancer.
Yuichiro Tsukada(National Cancer Center Hospital East), Takayuki Yoshino(University of Tsukuba), Takeshi Sasaki(Sapporo Medical University), Hiroyoshi Nishikawa(Immunité et Cancer), Yuji Nishizawa(National Cancer Center Hospital East), Daisuke Kotani(National Cancer Center Hospital East), Yosuke Togashi(Okayama University), Shigenori Homma(Hokkaido University), Hideaki Bando(Aichi Cancer Center), Yoshito Komatsu(Hokkaido University Hospital), Masaaki Ito(National Cancer Centre Japan), Akihiro Sato(Yokohama Municipal Citizen's Hospital), Tetsuo Akimoto(Tokyo Women's Medical University), Yoshihiro Matsuno(Hokkaido University Hospital), Motohiro Kojima(Chiba Cancer Center), Yutaka Hatanaka(Hokkaido University), Satoshi Yuki(Hokkaido University Hospital), Shota Fukuoka(National Cancer Research Institute), Naoki Nakamura(St. Marianna University School of Medicine), Koji Inamori(National Cancer Center Hospital East)
Cited by 3
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k